GALAPAGOS NV
CRL AI-extracted
Undisclosed program
cell therapy activities
Date
TBD
FDA decision · Date TBD estimated
What's at stake An FDA complete response letter on Undisclosed program for cell therapy activities is in focus around Date TBD.
“The remaining Galapagos organization expects to be a lean organization of approximately 35-40 employees by the end of 2026, repositioned for long-term growth through transformational business development, while maintaining a dedicated prese”

Provenance

2 sources on file.

Link copied ✓